ArticleThe Journal of dermatology2025

Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 Monotherapy.

Ken Horisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.